Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation

IgA Nephropathy (IgAN) is a common cause of end-stage kidney disease worldwide. Unfortunately, the exact pathogenesis of IgAN remains uncertain without any targeted therapy. While kidney transplantation remains the gold standard treatment for those with end-stage kidney disease from IgAN, recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Akhil, Hariharan, Sundaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964927/
https://www.ncbi.nlm.nih.gov/pubmed/32047846
http://dx.doi.org/10.1097/TXD.0000000000000963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964927/
https://www.ncbi.nlm.nih.gov/pubmed/32047846
http://dx.doi.org/10.1097/TXD.0000000000000963

Ejemplares similares